Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis April 12, 2022
Molecular Assemblies Announces $25.8 Million Series B Financing to Initiate Key Customer Program for Commercial Access to Fully Enzymatic DNA Synthesis March 15, 2022
Molecular Assemblies Awarded NIH Phase I SBIR Grant to Develop a Fully Enzymatic DNA Synthesis Process to Propel Synthetic Biology October 19, 2021
Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access April 15, 2021
Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing March 2, 2021
Molecular Assemblies Appoints Phil Paik, Ph.D., Vice President, Platform Development December 10, 2020
